Gadoxetic acid-based hepatobiliary MRI in hepatocellular carcinoma

BACKGROUND & AIMS: SORAMIC is a prospective phase II randomised controlled trial in hepatocellular carcinoma (HCC). It consists of 3 parts: a diagnostic study and 2 therapeutic studies with either curative ablation or palliative Yttrium-90 radioembolisation combined with sorafenib. We report the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricke, Jens, Steffen, Ingo G., Bargellini, Irene, Berg, Thomas, Bilbao Jaureguizar, José Ignacio, Gebauer, Bernhard, Iezzi, Roberto, Loewe, Christian, Karçaaltincaba, Musturay, Pech, Maciej, Sengel, Christian, van Delden, Otto, Vandecaveye, Vincent, Zech, Christoph J., Seidensticker, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578758/
https://www.ncbi.nlm.nih.gov/pubmed/33103093
http://dx.doi.org/10.1016/j.jhepr.2020.100173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578758/
https://www.ncbi.nlm.nih.gov/pubmed/33103093
http://dx.doi.org/10.1016/j.jhepr.2020.100173

Ejemplares similares